Changes in continence and erectile function between 2 and 4 years after radical prostatectomy. By Glickman et al 2009

and

Counseling the post-radical prostatectomy patients about functional recovery: High predictiveness of current status. By Vickers et al 2014

Sexual function in men with castrate levels of testosterone: Observations of a subgroup of sexually active men with prostate cancer undergoing androgen deprivation therapy. By Ng et al. 2014

Can physical activity prevent physical and cognitive decline in postmenopausal women? A systematic review of the literature. By Anderson et al. 2014

Survival and clinical metastases among prostate cancer patients treated with androgen deprivation therapy in Sweden. By Banefelt et al. 2014 

Cognitive functioning in men receiving androgen deprivation therapy for prostate cancer: a systematic review and meta-analysis. By McGinty et al. 2014

Androgen deprivation therapy complications. By Allan et al. 2014 

Fifteen-year survival outcomes following primary androgen-deprivation therapy for localized prostate cancer. By Lu-Yao et al. 2014 

Corpulence is the crucial factor: Association of testosterone and/or obesity with prostate cancer stage. By Jentzmik et al. 2014 

Health care costs for prostate cancer patients receiving androgen deprivation therapy: treatment and adverse events. By Krahn et al. 2014 

Differences in major depressive disorder and generalised anxiety disorder symptomatology between prostate cancer patients receiving hormone therapy and those who are not. By Sharpley et al. 2014